Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 18 Aug 2026 for Revelation Biosciences, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jess Roper: trading record in brief
Jess Roper is a declared insider at 3 companies; the most frequent names are Revelation Biosciences, Inc., Biolase, Inc and Dexcom Inc. Between 22 January 2016 and 17 August 2026, the trades on record add up to 7 filings.
The open-market record consists of 1 sale, with no purchase. The totals do not cover 1 filing with an undisclosed amount. Besides market trades, the filings include 5 share grants.
On 18 August 2026 came the latest disclosure, a share grant in Revelation Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jess Roper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
32,011 shares0Common StockSEC:0001193125-26-355659:0
1,591 shares@ US$1.854.7% of flowCommon StockSEC:0001193125-26-039700:0
41,981 shares@ US$0.9061.4% of flowCommon StockSEC:0001193125-26-010613:0
15,625 shares@ US$1.2896.2% of flowCommon StockSEC:0001193125-25-260415:0
181 shares@ US$3.87100.0% of flowCommon StockSEC:0000950170-25-020113:0
345.863 sharesSeries G Preferred StockSEC:0000899243-22-016097:0
3,518 sharesCommon StockSEC:0001093557-16-000420:0
7 of 7 declarations
